Ƒumeŋutinunya OEM ODM Nuƒle ƒe Agbalẽ Dzĩ na Latin Amerika Mamãlawo

     

Latin Amerika ƒumeŋutinunyalawo wɔa dɔ le medtech ƒe dzogoe siwo ŋu wowɔ ɖoɖo ɖo wu, siwo me wowɔa ɖoɖo ɖe nuzazãwo ŋu le wu la dometɔ ɖeka. Wò asitsatsa dzidzedzekpɔkpɔ nɔ te ɖe lever eve siwo nàte ŋu atrɔ asi le ŋutɔŋutɔ dzi: OEM/ODM hadɔwɔla si nètia kple mɔ si dzi nèwɔa nubabla le hena nyonyome, nudɔdɔ, kple co‐development. Agbalẽ ɣi sia naa nuƒlefefegbalẽ wò be nàda nudzralawo kpɔ, aɖe afɔku ƒe ŋkɔ dede agbalẽ me, eye nàtu ŋutete ɖo na adzɔnu siwo to vovo evɔ màtsɔ wò adzɔnu ƒe dzesi ade sedziwɔwɔ ƒe nukunuwo me o.

Nubabla lae nye esi: viɖe sesẽtɔ kekeake si le mamalawo ŋu le Brazil, Argentina, Chile, Colombia, kple Peru menye asixɔxɔ ɖeɖeko o. Enye hadomeɖoɖowɔwɔ kple ƒumeŋutinunya OEM ODM wɔla si ate ŋu awɔ ɖeka kpli wò—aɖo kpe dɔwɔwɔwo dzi, awɔ kpɔɖeŋu kabakaba, eye wòado alɔ ame etɔ̃lia ƒe dodokpɔ—eye wògale ƒoƒom ɖe game dzi ɖoɖo ɖe amewo dzi eye wòle SLA siwo me kɔ siwo dzi nàte ŋu awɔ ɖo la nam.

Nuŋlɔɖi sia nye kpeɖodzi‐kplɔ eye wòle dedie le sedziwɔwɔ me. Edoa ka kple dzɔtsoƒe gbãtɔwo alo esiwo dzi woda asi ɖo le afisiafi hena sedede ƒe mɔkpɔkpɔwo kple nyonyome ƒe nuwɔnawo, eye wòɖea esiawo gɔme ɖe nuƒledɔwɔnu siwo nàte ŋu azã etsɔ me.

Nu vevi siwo woatsɔ ayi teƒe bubuwo

• Do co‐development ŋutete ɖe nɔƒe gbãtɔ: bia be woawɔ ɖoɖo ɖe kpeɖodzinana si woŋlɔ ɖi (IQ/OQ/PQ), tɔtrɔdzikpɔkpɔ SOPs, kple nuwo/mɔ̃wo dodokpɔ ƒe kpeɖodzi siwo sɔ ɖe ASTM/ISO kple asitsatsa ƒe mɔwo nu.

• Wɔ nubabla kple nusi nàte ŋu adzidze: ɖe OTD/OTIF, dedienɔnɔ ƒe nudzraɖoƒe, kple nudzɔdzɔ kpata ƒe ɖoɖowɔwɔ ƒe SLAwo gɔme le adzɔnuwo ƒe ƒomea nu; de kpeɖodzi ƒe gomenɔamesiwo kple tohehe/gaxɔgbalẽvi siwo bla ɖe KPI siwo woate ŋu adzro ŋu.

• Tu ŋkɔ ŋɔŋlɔ ƒe dzadzraɖo ɖo le ɣeyiɣi ɖeka me: woawɔ mɔ̃ɖaŋu ŋuti nuŋlɔɖiwo wòasɔ ɖe EU MDR Annex II/III ƒe ɖoɖowo kple FDA ƒe mɔkpɔkpɔ siwo menye dɔdamɔnu o nu; ɖo kpe Brazil B‐GMP kple Colombia UDI ƒe ɣeyiɣiɖoɖowo dzi kple dziɖuɖu ƒe nyatakakadzraɖoƒewo.

• Bia be woawɔ OEM/ODM ƒe kpeɖodzinu blibo aɖe do ŋgɔ: tɔtrɔdzikpɔkpɔ ƒe dɔwɔwɔ ƒe ɖoɖo, dɔwɔwɔ ƒe kpeɖodzi matriki, kpɔɖeŋu me toto ƒe ɖaseɖigbalẽ, kple nuwo/biocompatibility/sterylization kpeɖodzi.

• Zã asixɔxɔ kple afɔku‐mamã ƒe ɖoɖoa: MOQ ƒe hatsotsowo, lead‐time bands, FX/tariff pass‐through logic, kple after‐sales SLA (response, repair, spares) be nàkpɔ margins ta.

---

Nusitae co‐development kple ƒumeŋutinunya OEM ODM zɔhɛ nyuitɔ trɔa emetsonuwo

LATAM ƒe nudzadzra ƒe tsatsam didi siwo amekolawo xɔxɔ, ɣeyiɣi si woɖo ɖi na dɔbiagbalẽvi, kple ŋkɔ dede agbalẽ me sesẽe ʋãa nudzralawo le LATAM. Ƒã hafi agbalẽdzraɖoƒe si wozãna ɖaa ƒoa nu tso nusiwo wò amekolawo bia ŋutɔŋutɔ le akɔta, nuveviwɔame, kple ƒunukpeƒewo ŋu. Ƒumeŋutinunya ƒe OEM ODM ƒe hadɔwɔla si si co‐development practices tsitsiwo le na nète ŋu trɔa asi le nɔnɔmeawo ŋu le teƒe ɖeka, gbugbɔa nyawo gblɔna kabakaba, eye nèŋlɔa kpeɖodziwo ɖi le mɔ siwo dzi sedzikpɔlawo kple kɔdzi kɔmitiwo lɔ̃na ɖo nu.

Nuka koŋue nyona ɖe edzi ne ŋgɔyiyi ɖekae nye nu ŋutɔŋutɔ eye menye nyagbɔgblɔ dzro aɖe ko o?

• Design‐to‐first‐case kabakaba wu to prototyping kabakaba si bla ɖe kpeɖodziɖoɖo siwo woɖe fia ŋu.

• Afɔku si le ɖoɖowɔwɔ me dzi ɖe kpɔtɔ ne mɔ̃ɖaŋu ŋuti nuŋlɔɖiwo sɔ kple xɔtuɖoɖo siwo wonya (le kpɔɖeŋu me, EU MDR Annex II/III), kple ne dodokpɔ ƒe ɖoɖo siwo menye dɔdamɔnu o sɔ ɖe mɔ̃a nu.

• Vovototodedeameme si woate ŋu akpɔ kple ŋku kple vovototodedeameme kple haƒonu siwo woɖɔ ɖo ɖe nutoa me ƒe dzesiwo ŋu—womatsɔ amehehe si woate ŋu akpɔ alo agbugbɔ aɖo kpe edzi asa vɔe o.

Ne èda nudzrala eve siwo ƒe asi sɔ la kpɔ la, zi geɖe la, àtia esi ƒe kpeɖodzi ŋutinya si nyo wu: IQ/OQ/PQ blibo, tɔtrɔdzikpɔkpɔ ƒe nusiwo me kɔ, kple ame etɔ̃lia ƒe dodokpɔ ƒe kpekpeɖeŋu. Emae nye hadɔwɔla si ate ŋu ato kɔdzi ƒe agbalẽdzikpɔkpɔ me eye wòana wò pɔmpia nayi edzi anɔ zɔzɔm.

---

LATAM ƒe ɖoɖowɔɖi ƒe fefegbalẽ le ŋkubiãnya me

Brazil — ANVISA RDC 751/2022 kple B‐GMP

• Ƒumeŋuɖui ƒe hatsotso III hiã Registro kple mɔ̃ɖaŋu ŋuti nyatakaka blibo; wole mɔ kpɔm be Brazil GMP (B‐GMP) ƒe ɖaseɖigbalẽ nanɔ adzɔnuwo wɔlawo si. Numedzodzro siwo ŋu ŋkɔ le ɖe ɖoɖo xoxowo ɖɔliɖɔli kple woƒe ɖoɖowɔwɔ ɖe IMDRF ƒe atsyã ƒe mɔ̃ɖaŋu ŋuti nuŋlɔɖiwo ŋu me. Kpɔ Johner Institute ƒe numekuku le atikewɔnuwo ƒe mɔɖeɖe le Brazil kple asi ŋuti nyatakakawo abe Rimsys ƒe Brazil dukɔ ƒe axa ene dzi wɔwɔ hena nya siwo ƒo xlãe kple dɔwɔwɔ ƒe gɔmesesewo.

• UDI: Evelia dzɔtsoƒe geɖewo ƒo nu tso UDI ƒe dzesidede ɣeyiɣi mamlɛ siwo wowɔna vivivi ŋu na afɔku ƒe hatsotso siwo lolo wu; ɖo kpe ɖoɖowɔɖi si li fifia dzi tẽ le ANVISA ƒe sedede ƒe mɔnu hafi nàwu dzesideŋkɔwo kple IFUwo nu.

Colombia — INVIMA UDI kple gɔmesese ƒe dzidzenu

• Nyametsotso 1405/2022 to UDI‐DI coding kple gɔmesese ŋuti nyatakaka si wotsɔ ɖo ɖa to INVIMA ƒe mɔ̃ dzi vɛ. Aɖaŋuɖoɖo yeyewo de dzesi mɔ̃a ƒe go‐live le Feb 8, 2024 eye woɖe ɣeyiɣi mamlɛawo vivivi va ɖo 2025/2026 le mɔ̃ ƒe hatsotso nu. Kpɔ wò mɔ̃a ƒe hatsotso kple ɣeyiɣi mamlɛawo ɖa le INVIMA ƒe kadodo siwo dziɖuɖua da asi ɖo me. Nya siwo ƒo xlãe si ŋu viɖe le: Veraque Consulting ƒe numeɖela le gɔmesese ƒe dzidzenu kple UDI ƒe mɔnu ŋu kple xexeame katã ƒe sedede yeye tso Emergo gbɔ si ƒo nu tso dɔwɔwɔ ŋu kpuie.

EU MDR kple FDA ƒe ɖoɖowo abe nuŋlɔɖiwo ƒe sekewo ene

• EU MDR Annex II/III zazã abe megbeƒu ene na wò mɔ̃ɖaŋu ŋuti nuŋlɔɖiwo kpena ɖe kpeɖodziwo ŋu be woawɔ ɖeka le asiwo me. Nuŋɔŋlɔ si woƒo ƒu ɖekae nye woate ŋu akpɔe le EUR‐Lex , si gblɔ mɔ̃a ƒe numeɖeɖe si wokpɔ mɔ na, ​​GSPR ƒe anyigbatata, kple kpeɖodzi/da asi ɖe edzi me nyawo, kpakple PMS/PMCF ƒe asinudɔwɔwɔwo hena nusiwo wotsɔ dea lãme na ame.

• Le United States ƒe mɔ siwo kpɔa ŋusẽ ɖe mɔkpɔkpɔ siwo menye dɔdamɔnu o dzi le xexeame katã gome la,... FDA ƒe mɔfiame si woŋlɔ ku ɖe kpeɖodzi ƒe mɔkpɔkpɔwo na 510(k) implant devices kple agency’s ISO 10993‐1 ƒe biocompatibility mɔfiamewo na dodokpɔ si wotu ɖe afɔku dzi, sterilization validation (SAL 10−6), kple shelf‐life mɔnu siwo wòle be nuƒlehawo nabia le OEM files me la me kɔ.

Argentina (ANMAT) kple Peru (DIGEMID) — ɖo kpe nya tɔxɛwo dzi le dziɖuɖua ƒe nyatakakadzraɖoƒewo

• Asi eveawo siaa hiã nutoa me tɔwo kple mɔ̃ɖaŋu ŋuti nuŋlɔɖi blibowo, zi geɖe la, wotsɔa Spaingbe me dzesidewo kple IFUwo ɖoa wo ŋu. Esi wònye be dispositions kple portals trɔna ta la, tu kpeɖodzi ƒe afɔɖeɖe ɖe wò RACI me eye nàɖo kpe nudidi yeyewo dzi le ANMAT ƒe nyatakakadzraɖoƒe si dziɖuɖua ɖo kple DIGEMID ƒe portal hafi dossier natsi tsikpe me eye nàtae.

---

Supply and delivery framework si dzi nàte ŋu awɔ nubabla le

Màte ŋu akpɔ nusi mèɖe o la gbɔ o. Le nubablawo kple S&OP kpekpewo me la, zi geɖe la, akpa vovovowo zãa OTD, OTIF, kple 'lead time' le mɔ si mebɔbɔ o nu. Trɔ gbegbɔgblɔ kple dzidzenuwo ɖe ɖoɖo nu be amesiame naɖi anukware eye wòana woawɔ ɖe credit/penalties dzi.

Gɔmeɖeɖewo kple mɔnu si wozãna

• OTD (On‐Time Delivery): nudɔdɔ si wotsɔ yi le ŋkeke si dzi wodo ŋugbe na alo do ŋgɔ nɛ, si wodzidze le Incoterm ƒe asidede asi si dzi wolɔ̃ ɖo (le kpɔɖeŋu me, FCA/FOB/CIF). Tia ɣeyiɣi ɖeka hena dzidzedze—ŋkeke si dzi nèwɔ dɔa tsã tsɔ wu kpeɖodzi be wotsɔe vɛ—eye nàŋlɔe ɖe MSA me.

• OTIF (On‐Time, In‐Full): nudɔdɔ si wotsɔ yi teƒe nyuitɔ, le game dzi, eye wowɔ fli me nuawo katã kple agbɔsɔsɔmeawo dzi. Akpa aɖe yɔyɔ menye 'de blibo o.' o.

• Fill rate: nudɔdɔ ƒe fli alo unit siwo woɖo ɖa ƒe alafa memamã vs. wobia le fesre si ŋugbe wodo la me. Zã line‐item fill rate na implants be nàlé nu suesuesue siwo to vovo gake wole vevie ŋutɔ.

Taɖodzinu ƒe hatsotsowo (siwo ŋu kpeɖodzi le, siwo ŋu woaɖo kpee le wò RFP me) .

• Nusiwo wotsɔ dea ame me vevie (Klass III, amekoko ƒe ɖoɖo): OTD ≥95%; OTIF ≥93–95% ƒe xexlẽme; line‐item fill rate ≥98% na SKU siwo wodzra ɖo. Kpata ƒe fesre <gaƒoƒo 24–48 le afisi wòanya wɔ le.

• Kpekpeɖeŋunu/dɔwɔnu siwo mele vevie o: OTD ≥92%; OTIF ≥90–92% ƒe xexlẽme.

KPI kplɔ̃ si wɔa dɔ nyuie si nàtsɔ ade wò MSA

Adzɔnuwo ƒe ƒomea me	Ɣeyiɣi si woɖo ɖi (ɣletigbalẽ dzi ŋkekewo)	Nudzraɖoƒe ƒe ɖoɖo	Taɖodzinu OTD	Taɖodzinu OTIF	Line‐item fill
Akɔta ƒe akpa siwo wotsɔ dea ame me (woƒe lolome siwo wodzra ɖo ɖe nudzraɖoƒe) .	14–30 me	Nutome dedienɔnɔ ƒe nudzraɖoƒe; nudɔdɔ na SKU 30 siwo le ŋgɔ wu	≥95% .	≥95% .	≥98% .
Akɔta/nuveviwɔame ƒe vovototo siwo wowɔ ɖe ɖoɖo nu	30–60 ƒe axa 10	Tue ɖe ɖoɖo nu	≥92% .	≥92% .	≥95% .
Trauma plates/screws (dzidzenu) .	21–45 ƒe axa 10	Titina dedienɔnɔ ƒe nudzraɖoƒe + ŋgɔgbe nudzraɖoƒe	≥94% .	≥93% .	≥97% .
Dɔwɔnuwo ƒe hatsotsowo (gbugbɔgawɔ/wu enu) .	30–60 ƒe axa 10	Rotational pool kple beléle na SLA	≥92% .	≥90% .	≥95% .

Dzidzedze ƒe nuŋlɔɖi: Ŋlɔe nenye be wobu OTD le eɖoɖo (FCA/FOB) alo eɖoɖo (CIF/DAP) kple alesi wokpɔa ŋusẽ gã ƒe vovototowo gbɔe. Ne èyɔ dzidzenuwo le ememe la, wɔ ɖeka kple KPI mɔnu siwo wonya ale be wò dashboardwo nasɔ kple nusiwo nudzralawo kpɔna le woƒe QBRwo me. Ne èdi mɔnu ƒe megbenyawo le OTD ƒe gɔmesesewo kple nudzralawo ƒe KPI ƒe ɖoɖowɔwɔ ŋu la, kpɔ numedzodzro ŋutɔŋutɔ si ku ɖe ɣeyiɣi dzi ɖoɖo ƒe xexlẽdzesiwo ŋu si ɖe akɔntabubu ƒe mɔ̃tetrewo kple ɖoɖowɔwɔ ɖe wo nɔewo ŋu le ƒuƒoƒowo dome.

Logistics SLA kple ɖoɖowɔwɔ ɖe nudzɔdzɔ kpatawo ŋu

• Agbalẽŋɔŋlɔ kple nuŋlɔɖiwo wɔwɔ SLA: ɖo kpe nutsotso siwo wotso dzi (le kpɔɖeŋu me, nuŋlɔɖi siwo wotsɔ ɖo ɖa ≥3 dɔwɔŋkekewo do ŋgɔ na meliɖoɖo), asitsatsa ƒe adzɔxegbalẽviwo ƒe nyateƒetoto me dzodzro, kple adzɔxexe ƒe se siwo wɔ ɖeka.

• Adzɔnuwo ƒe asitsatsa kple wo ɖeɖeɖa: tia asitsalawo; ɖe escalation trees kple proof‐of‐clearance ƒe ɣeyiɣiɖoɖowo gɔme; lé fefegbalẽ siwo ku ɖe dukɔ aɖewo koŋ ŋu me ɖe asi.

• Kpata ƒe ɖoɖowɔwɔ: ŋlɔ nusiwo aʋã ame (le kpɔɖeŋu me, amekoko‐critical backorder), ʋuɖoɖo ƒe mɔnu siwo li, kple nyametsotso ƒe ŋusẽ. Taɖodzinu ƒe ŋuɖoɖo le <24–48 gaƒoƒo me na dɔléle sesẽwo.

• Traceability kple UDI: ɖo kpe dzeside/UDI ƒe dzadzraɖo dzi be woaƒo asa na dukɔmeviwo ƒe dukɔmevinyenye alo kɔdzi ƒe amewo xɔxɔ ƒe gbegbe.

Nukatae wowɔa nu sesẽa? Elabena tender scorings kple amekola ƒe kakaɖedzi kpea fu ne backordered size ɖeka te fli ɖe OR ŋkeke aɖe me. Ne èna OTD/OTIF zu nubabla la, èkpɔa mɔnu siwo dzi nàto aɖɔ mɔa ɖo evɔ màto ƒomedodo ɖeɖeko ƒe ɖɔɖɔɖowo dzi o.

---

OEM/ODM mɔ̃ɖaŋununya ƒe kpeɖodzinu ƒe agbalẽvi: alesi nyui le

Esiae nye ƒumeŋutinunya OEM ODM ƒe dodokpɔ ƒe dzi. Bia amesiwo di be yewoawɔ dɔ kplii be woana agbalẽ blibo si me woate ŋu agbugbɔ ŋku alé ɖe eŋu. Taɖodzinua menye agbalẽwo wɔwɔ le eya ŋutɔ ƒe nyonyo ta o—enye be woaɖo kpe edzi be mɔ̃a kple dɔwɔwɔ ŋuti kpeɖodziwo ate ŋu anɔ te ɖe agbalẽdzikpɔkpɔ, ŋkɔ ŋɔŋlɔ, kple kɔdzi ƒe ŋkuléle ɖe eŋu nu.

1. Trɔ dziɖuɖu SOP kple nyametsotsoti

• Nusiwo ʋãa ame: nu ƒe grade ƒe tɔtrɔ, nudzrala ƒe tɔtrɔ na akpa vevi aɖe, mɔ̃ɖaŋununya ƒe ɖoɖowɔɖi ƒe tɔtrɔ, anyigba dzi atikewɔwɔ ƒe tɔtrɔ, dɔlékuiwutike ƒe tsatsam ƒe yeyewɔwɔ, dzesidede/UDI ƒe tɔtrɔ, alo nubabla ƒe nudzrala ƒe asitɔtrɔ.

• Ŋusẽkpɔɖeamedzi ƒe dodokpɔ: wowɔ nɔnɔmetata na afɔkudzikpɔkpɔ (ISO 14971), GSPRwo (ne wozã MDR ƒe ɖoɖo), kple asi ƒe nyatakakawo. Bia be woade asi RA/QA te eye woawɔ nyametsotso si me kɔ le gbugbɔgaɖoanyi ŋu (ɖeke meli o/afã/blibo) kple susu.

• Agbledzi kadodo: ne nane si ate u agblẽ nu le dedienɔnɔ/dɔwɔwɔ ŋu le agblea me la, kpɔ egbɔ be PMS/PMCF ƒe nyawo de eme eye wodzi ɖe edzi va ɖo ŋudzɔnɔnɔ ƒe ɖoɖowo gbɔ.

2. Dɔwɔwɔ ƒe kpeɖodzinana ƒe ɖoɖo (IQ/OQ/PQ) .

• IQ: dɔwɔnuwo, dɔwɔnuwo, kɔmpiutadziɖoɖowo ƒe tɔtrɔwo, kple nutome ƒe dzeside siwo woŋlɔ ɖi ɖe nɔnɔme tɔxɛwo nu, eye wotu lɔlɔ̃ ɖe edzi ƒe dzidzenuwo kple tete ɖa.

• OQ: parameter kuxiwo le normal/worst‐case ranges katã me, de dzesi process parameters veviwo kple seɖoƒewo ɖoɖo ɖe dziɖuɖu ŋu; kpeɖodzi be GR&R le afisi wozãa dzidzenuwo le.

• PQ: wɔwɔ edziedzi ƒe duƒuƒu geɖe siwo ɖea ŋutete fiana (CpK le afisi wòsɔ le) kple kpɔɖeŋuɖoɖo siwo woɖo do ŋgɔ; na vidzidzi, kpeɖodzi si ɖe SAL 10−6 fia kple nubabla ƒe kpeɖodzi le ISO 11607 nu.

• Nuŋlɔɖiwo ƒe anyigbatata: kpeɖodzinana ƒe ɖoɖo gã si do ƒome kple ɖoɖowɔɖi/nyatakaka ɖekaɖekawo, si me woate ŋu akpɔ DHF kple tɔtrɔ ƒe nuŋlɔɖiwo le. Ne èdi be yeanya nu nyuitɔ ƒe ɖoɖo kple emenyawo ƒe sɔsɔ kple EU MDR tech doc ƒe mɔkpɔkpɔwo la, kpɔ Team‐NB ƒe mɔ̃ɖaŋu ŋuti nuŋlɔɖiwo ƒe ɖoƒe gbalẽ.

3. Nusiwo wotsɔ wɔe kple dodokpɔ ƒe nuŋlɔɖi

• Nusiwo wozã: Kukuɖenuŋu ƒe ɖaseɖigbalẽ siwo léa dzoxɔxɔ/lot yometiti vaseɖe dzesi siwo wonya dzi (le kpɔɖeŋu me, ASTM F136 Ti‐6Al‐4V ELI, ASTM F138/139 316L, ASTM F1537 CoCr). Lé nudzrala ƒe ɖaseɖigbalẽwo kple lɔlɔ̃ ɖe edzi ƒe dzidzenuwo me ɖe asi.

• Mɔ̃ɖaŋu dodokpɔ: dzidzenu siwo sɔ ɖe mɔ̃a nu (le kpɔɖeŋu me, ASTM F1717 na aklã ƒe wɔwɔmewo, ASTM F2077 na IBF mɔ̃wo, ASTM F382 na agbalẽviwo, ASTM F543 na gaviwo), tiatia vɔ̃ɖitɔ kekeake ŋuti nuŋlɔɖiwo, kple tsɔtsɔ sɔ kple nufiame mɔ̃wo le afisi wòsɔ le. FDA ƒe dɔwɔwɔ ƒe dzidzenuwo tata na gbagbãƒe ƒe agbalẽviwo nye alesi dzidzenuwo tsɔa seke ɖoa nyatakakawo ɖa ƒe kpɔɖeŋu nyui aɖe.

• Biocompatibility: ɖoɖo si sɔ ɖe ISO 10993‐1 ƒe nusiwo woɖena fiana ƒe hatsotso nu; atikewo ƒe dzesiwo ɖeɖefia kple aɖiŋutinunya ƒe afɔku ƒe dodokpɔ le afisi woɖee fia le; dodokpɔ ƒe dodokpɔxɔ ƒe ɖaseɖigbalẽ ƒe kpeɖodzi.

• Dɔlékuiwutikewo zazã kple wo babla: mɔnu tɔxɛ aɖe ƒe kpeɖodzinana kple nusiwo susɔ (ne EtO); packaging validation per ISO 11607 kple mama ƒe nɔnɔmetata kple nutrenu ƒe blibonyenye.

• Reference index: ememe index mapping si nyatakaka doa alɔ GSPR alo asi‐koŋ ƒe mɔkpɔkpɔ kawo. Ne èdi dzidzenu siwo ku ɖe nusiwo wotsɔ dea lãme na ame ƒe agbalẽ gbadza aɖe la, kpɔ ASTM ƒe atikewɔmɔ̃ kple nusiwo wotsɔ dea lãme na ame ƒe dzidzenuwo ƒe wɔwɔfia.

4. Kpɔɖeŋuwo me toto ƒe ɖaseɖigbalẽ

• DFM/DFA: nuwo wɔwɔ kple wo ƒoƒo ƒu me toto si woŋlɔ ɖi kple nuwɔnawo.

• Afɔku yeyewo: kadodo kple afɔkuwo me dzodzro kple nɔnɔme tɔxɛwo.

• Kpeɖodzi ƒe ɖoɖo: woɖe lɔlɔ̃ ɖe edzi ƒe dzidzenuwo me na kpɔɖeŋu ƒe ƒoƒo (dzidzeme, mɔ̃ɖaŋu, dɔwɔwɔ) kple afɔɖeɖe siwo kplɔe ɖo siwo ŋu wowɔ ɖoɖo ɖo.

• Asiɖeɖe le eŋu ƒe dzidzenuwo: alesi kpɔɖeŋu aɖe va zua design‐freeze candidate kple kpeɖodzi bubu siwo hiã.

Micro‐example si woate ŋu azã (si mede akpa aɖeke dzi o) .

• Le nudzrala ƒe dzesideɣi la, wò ƒuƒoƒoa biaa IQ/OQ/PQ ƒe ɖoɖo bliboa na vidzidɔ ƒe agbalẽvi yeye. OEM la tsɔa kpeɖodzinana ƒe ɖoɖo gã aɖe, OQ parameter nusɔsrɔ̃wo na mɔ̃ɖaŋununya kple passivation, eye PQ zɔna kple CpK ŋutete ƒe kpukpuiwo. Ètsɔa nyatakakawo ƒe kpɔɖeŋu tso woƒe mɔ̃ɖaŋu kple nubablɛ ƒe kpeɖodziwo me eye nèɖoa kpe edzi be wowɔ ɖoɖo ɖe ASTM F382 dodokpɔ ŋu le eƒe titrime si vɔ̃ɖi wu me. Nuwɔwɔ le gaglãgbe ƒe seƒe sia nye nusi bɔ ɖe adzɔnuwɔƒe tsitsiwo gome; le kpɔɖeŋu me, le subɔsubɔdɔwo ƒe wɔwɔfia le XC Medico gblɔ OEM/ODM dɔwɔwɔ ƒe ɖoɖowo kple nuwo wɔwɔ ƒe ŋutete siwo mamalawo ate ŋu ada asɔ hena woƒe sɔsɔ.

---

Dɔwɔnu siwo wozãna tsɔ ƒlea nu kple asixɔxɔ ƒe mɔnu ƒe ɖoɖo

Ele be wò RFP nana wòanɔ bɔbɔe na ƒumeŋuɖui OEM ODM dɔwɔƒe siwo ɖɔa ŋu ɖo be woawɔ nu ɖe ​​eŋu—eye wòasesẽ na nudzrala siwo medzra ɖo o be woaɣla dometsotsowo.

RFP kple nudzralawo ƒe agbalẽdzikpɔkpɔ ƒe nu veviwo

• QMS kple ɖoɖowɔwɔ: ISO 13485 ƒe ɖaseɖigbalẽ; ememe agbalẽdzikpɔkpɔ ƒe cadence; CAPA ƒe dɔwɔwɔ nyuie; aɖaŋuwɔwɔ dzi kpɔkpɔ ƒe ɖoɖowo; MDR‐style mɔ̃ɖaŋu ŋuti nuŋlɔɖiwo ƒe kplɔ̃ si dzi woŋlɔ nyawo ɖo; kpeɖodzi be UDI‐le dzadzraɖoɖi na asi siwo woɖo taɖodzinu na.

• Traceability kple dzadzɛnyenye: lot/heat traceability tso bar vaseɖe implant; calibration ɖoɖowɔɖi; xɔ dzadzɛwo ƒe hatsotsowo me toto kple nutome dzi kpɔkpɔ le afisi wòsɔ le.

• Dzesidede kple dodokpɔ: kpeɖodzinana ƒe ɖoɖo gã; IQ/OQ/PQ ƒe nɔnɔme le ɖoɖo nu; ame etɔ̃lia ƒe mɔ̃ɖaŋu/nu gbagbewo ƒe dɔwɔwɔ ƒe dodokpɔxɔ ƒe ɖaseɖigbalẽwo.

• Logistics kple service: standard lead‐time bands le adzɔnuwo ƒe ƒomea nu; OTD/OTIF ƒe ŋutinya; dedienɔnɔ ƒe nudzraɖoƒe ƒe aɖaŋuɖoɖo; ɖoɖowɔwɔ kpata ƒe ɖoɖowɔwɔ; after‐sales SLA (ŋuɖoɖo, dzadzraɖo, spare parts ƒe anyinɔnɔ).

Asixɔxɔ kple afɔku‐mamã ƒe mɔnuwo

• MOQ tiers: wowɔ ɖeka kple SKU ƒe vevienyenye kple ABC ƒe hatsotsowo; bu MOQ siwo kɔ wu ŋu na dekɔnu siwo ƒe duƒuƒu le sue ko.

• Lead‐time bands: wotaa wo eye wotoa wo me le ɣleti etɔ̃ ɖesiaɖe me; bla tohehe/gaxɔgbalẽviwo ɖe tohehewo ŋu le haƒohawo dzi na ƒome siwo me nudzraɖoƒewo le.

• FX kple tariffs: ɖe pass‐through thresholds gɔme eye nàto cadence me; bu kɔla ƒe kaƒomɔ̃wo ŋu na FX ƒe tɔtrɔ.

• SLA le nudzadzra megbe: ŋuɖoɖoɣiwo na mɔ̃ɖaŋunyabiasewo (le kpɔɖeŋu me, ≤24h), tɔtrɔɣi na dɔwɔnuwo dzadzraɖo, kple akpa siwo woaɖɔli ƒe anyinɔnɔ.

Ne wò RFP ɖo nyati siawo ɖe ɖoɖo nu nyuie la, nudzralawo ŋutɔ tiaa wo ɖokui. Amesiwo ateŋu ado alɔ co‐development la ana validation pack, KPI ŋutinya, kple stocking ɖoɖo ŋutɔŋutɔwo heheɖemegbe manɔmee.

---

LATAM ƒe asitsatsa ƒe ŋutete: ŋkɔ ŋɔŋlɔ, KOL hehenana, kple gazazã ƒe nyonyome ŋuti kpeɖodzi

Nu vevi siwo wowɔna le ŋkɔ ŋɔŋlɔ me kple dzadzraɖo ɖe dɔbiagbalẽvi ŋu

• Tu wò ŋkɔ ŋɔŋlɔ ƒe RACI kaba: amesi ŋlɔa IFU kple dzesidede, amesi ƒoa GSPR ƒe ɖaseɖigbalẽa nu ƒu, amesi tɔ gbegɔmeɖeɖewo le, eye amesi doa ka kple nutoa me tɔwo. EU MDR Annex II/III ƒe ɖoɖowo ƒe ahuhɔ̃e wɔwɔ naa nyatakakawo gbugbɔgazã le asiwo dome nɔa bɔbɔe eye wònana agbalẽdzikpɔkpɔwo nɔa bɔbɔe. Na afɔɖeɖe si woatsɔ aɖo kpe edzi na Brazil B‐GMP ƒe nɔnɔme kple Colombia UDI ƒe dɔdɔwo hafi woatae.

KOL ƒe hehenana kple vixɔxɔnyi

• Wɔ amekola ƒe hehexɔxɔ ƒe ɖoɖo kple wò OEM/ODM zɔhɛ: ame kukuwo ƒe dodokpɔxɔwo, instrument dry‐runs, kple case tiatia mɔfiame si sɔ ɖe device IFUs nu. Hehenana ƒe nuŋlɔɖiwo, vavalawo, kple nyaŋuɖoɖo kpena ɖe ame ŋu be woado alɔ tender dossiers kple ememe PMS.

Gazazã nyuie ƒe ɖoɖowɔwɔ (menye emetsonuwo ŋuti nyawo o) .

• Wɔ dɔ kple kɔdzidzikpɔlawo be woawɔ kpɔɖeŋu na nudzɔdzɔa ƒe gazazã bliboa: ga si woɖo be woatsɔ ade ame me, dɔwɔnu ƒe anyinɔnɔ, ga si woatsɔ agbugbɔ awɔ dɔe, susu siwo ku ɖe nudzɔdzɔa ƒe didime ŋu, kple afɔku ƒe tohehe siwo woatsɔ axe fe ɖe megbe. Zã kpɔɖeŋua nàtsɔ atsɔ tiatiawɔblɔɖewo asɔ kple wo nɔewo tsɔ wu be nàdo ŋugbe be dɔdaƒe deŋgɔ si màte ŋu aŋlɔ ɖi o.

---

Dzeɖoɖo ƒe nya siwo kpɔa numalawo ta

• Kpeɖodziwo ƒe asixɔxɔ: agbalẽdzikpɔkpɔ ƒe gomenɔamesiwo le kpeɖodzigbalẽwo ŋu (le NDA te), si me dodokpɔ ŋuti nyatakakawo kple tɔtrɔwo dzi kpɔkpɔ ŋuti nuŋlɔɖiwo hã le.

• Lead‐time ƒe ŋugbedodowo kple credits: credit siwo woxɔna ɖe nusiwo wotsɔ yi megbe na ƒome siwo me nudzraɖoƒewo le dzi; nusiwo woɖe le eme tẽ le ŋusẽ si gbɔ eme ta si woŋlɔ ɖi.

• Kpata ƒe ŋuɖoɖo: woɖe nusiwo aʋã ame kple ɖoɖowɔwɔ ƒe mɔnuwo me kple gazazãwo mama ƒe sewo.

• Tɔtrɔ ŋuti nyatakaka: gbeƒãɖeɖe do ŋgɔ ƒe fesrewo na tɔtrɔ ɖesiaɖe si abia be woagbugbɔ aɖo kpe edzi alo woana nyatakaka tso ɖoɖowɔwɔ ŋu; gomenɔamesi be woabia be woagbugbɔ aɖo kpe edzi ƒe akpa aɖe/ke bliboe.

• Mɔɖegbalẽ kple gbeadzi afɔɖeɖewo: agbanɔamedzi siwo me kɔ na numekuku ƒe kpekpeɖeŋu, ɣeyiɣiɖoɖo siwo woatsɔ aɖɔli wo, kple agbanɔamedzi siwo woatsɔ ayɔ amewo.

• IP kple mɔ̃ɖaŋununya ƒe asitɔtrɔ: ametakpɔkpɔwo na aɖaŋu siwo wowɔ ɖekae, mɔɖegbalẽ ƒe ɖoɖowo ne ele be nuwo wɔwɔ natrɔ, kple escrow na aɖaŋuwɔwɔ ƒe faɛl veviwo le nɔnɔme siwo woɖe fia me.

---

Afɔɖeɖe siwo kplɔe ɖo kple nunɔamesiwo

Action checklist si nàte ŋu adze egɔme le kwasiɖa sia me

• Ŋlɔ ƒumeŋutinunya OEM ODM ame 3–5 kpuiwo eye nàna RFP si bia be: ISO 13485, kpeɖodzinana ƒe ɖoɖo gã, kpɔɖeŋu IQ/OQ/PQ nyatakakawo, nuzazãwo/dodokpɔ ƒe dossier index, OTD/OTIF ŋutinya, nudzraɖoƒe ƒe ɖoɖo, kple nudzɔdzɔ kpata ƒe ɖoɖowɔwɔ SOP.

• Wɔ wò taɖodzinu ƒe ŋkɔ ŋɔŋlɔ ƒe nɔnɔmetata eye nàɖo kpe nudidi siwo li fifia dzi le ANVISA, INVIMA, ANMAT, kple DIGEMID ƒe nyatakakadzraɖoƒewo; tsɔ wò tech doc sɔ kple EU MDR Annex II/III eye nàƒo kpeɖodzi siwo menye dɔdamɔnu o siwo sɔ ɖe FDA nu nu ƒu.

• Ŋlɔ wò nuzazã kple asixɔxɔ ƒe mɔnu ƒe ɖoɖo si me KPI ƒe haƒoƒo siwo me kɔ, FX/adzɔxexe ƒe sewo, kple SLA le nudzadzra megbe; hadede kple ememe ganyawo kple dɔwɔnawo hafi woawɔ ɖoɖo.

Dɔwɔnu tiatia siwo ŋu ŋusẽ le siwo ŋu míeƒo nu tsoe le etame

• EU MDR ƒe nuŋɔŋlɔ si woƒo ƒu tso EUR‐Lex ŋu na Annex II/III ƒe xɔtuɖoɖowo.

• FDA ƒe kpeɖodzi mɔkpɔkpɔwo na 510(k) implant devices kple FDA ISO 10993‐1 ƒe mɔfiame na biocompatibility ɖoɖowɔwɔ.

• Brazil ƒe mɔ̃wo dzi dada ƒe kpukpui (Johner Institute) kple Rimsys Brazil ƒe nɔnɔmetata hena nya siwo ƒo xlãe ƒe ɖoɖowo gɔmesese; ɖo kpe UDI ƒe ŋkekewo dzi le ANVISA ƒe nyatakakadzraɖoƒea.

• Colombia UDI/gɔmesese ƒe dzidzenu ƒe nɔnɔme to Veraque Aɖaŋuɖoɖo kple a xexeame katã ƒe nyatakaka yeye tso Emergo ; ɖo kpe ɣeyiɣi mamlɛawo dzi le INVIMA dzi.

• ASTM implant dzidzenuwo ƒe wɔwɔfia na nuwo kple mɔ̃ɖaŋu dodokpɔ ƒe kekeme.

• OTD mɔnu numeɖela na KPI ƒe ɖoɖowɔwɔ le ƒuƒoƒowo dome.

• Team‐NB mɔ̃ɖaŋu nuŋlɔɖiwo ƒe dɔwɔwɔ nyuitɔ ƒe agbalẽ na MDR‐style file structure.

---

Megbenyawo: Nyagɔmeɖegbalẽ

• OTD (On‐Time Delivery): Nusiwo woɖo ɖa le ŋkeke si dzi wodo ŋugbe na la ƒe alafa memamã le Incoterms ƒe teƒe si dzi wolɔ̃ ɖo.

• OTIF (On‐Time, In‐Full): Nusiwo woɖo ɖe game dzi ƒe alafa memamã kple nuawo katã kple agbɔsɔsɔme abe alesi wobiae ene.

• IQ/OQ/PQ: Dɔwɔwɔ, Dɔwɔwɔ, kple Dɔwɔwɔ ƒe Dzeside—dɔwɔwɔ ƒe kpeɖodzinana ƒe afɔɖeɖe siwo kplɔ wo nɔewo ɖo.

• GSPR: Dedienɔnɔ kple Dɔwɔwɔ ƒe Nudidi Gãwo le EU MDR ƒe Megbenya I te.

• SAL 10−6: Vidzidzi ƒe Kakaɖedzi ƒe Dzidzenu si woɖo taɖodzinu na le vidzidzi ƒe nuwuwu ƒe kpeɖodziwo me.

• UDI: Mɔ̃ ƒe Dzesidede Tɔxɛ si wozãna hena dzesidede kple kplɔkplɔ.

De dzesii le adzɔnu ƒe ŋkɔ yɔyɔ ŋu: Agbalẽ ɣi sia tsɔ kpɔɖeŋu ɖeka si mede akpa aɖeke dzi o, si le nya siwo ƒo xlãe me si ƒo nu tso OEM/ODM dɔwɔwɔ ƒe ɖoɖowo ŋu le XC Medico ƒe nyatakakadzraɖoƒea ale be nuxlẽlawo nate ŋu akpɔ alesi woada adzɔnuwo wɔwɔ kple woƒe kpeɖodzinana ƒe nuwɔnawo kpɔ le nuwɔna me. Ne èdi nya siwo ƒo xlãe la, dzro eme XC Medico ƒe dɔwɔnawo ƒe wɔwɔfia.